Biosimilar

Results: 639



#Item
291Pharmaceutical sciences / Health / Pharmacology / Food law / Prescription Drug User Fee Act / Biosimilar / Biologic / Fee / Federal Food /  Drug /  and Cosmetic Act / Food and Drug Administration / Pharmaceuticals policy / Medicine

FY 2013 BsUFA Financial Report

Add to Reading List

Source URL: www.fda.gov

Language: English
292Pharmacology / Food and Drug Administration / Pharmaceuticals policy / Therapeutics / United States Public Health Service / Biosimilar / Biologic / Appropriation bill / Federal Food /  Drug /  and Cosmetic Act / Medicine / Pharmaceutical sciences / Clinical research

FY 2013 BsUFA Financial Report - Appendix A

Add to Reading List

Source URL: www.fda.gov

Language: English
293Clinical pharmacology / Food and Drug Administration / Therapeutics / United States Public Health Service / Piperazines / Biosimilar / Ipilimumab / Food and Drug Administration Amendments Act / Moxifloxacin / Pharmacology / Clinical research / Pharmaceutical sciences

FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 5, 2013 DISCLAIMER STATEMENT The attached package contains background information prepared by the Food and D

Add to Reading List

Source URL: www.fda.gov

Language: English
294Pharmaceutical industry / Biotechnology / Pharmaceuticals policy / Food and Drug Administration / Biosimilar / Biologic / Novartis / Biopharmaceutical / Regulatory affairs / Pharmaceutical sciences / Pharmacology / Clinical research

0 d David Drake Executive Director, Federal Government

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-03-17 17:36:45
295Pharmacology / Clinical research / Prescription Drug User Fee Act / Fee / Biosimilar / Origination fee / Food and Drug Administration / Pharmaceuticals policy / Pharmaceutical sciences

FY 2013 BsUFA Financial Report

Add to Reading List

Source URL: www.fda.gov

Language: English
296Clinical pharmacology / Food and Drug Administration / Therapeutics / United States Public Health Service / Biosimilar / Biologic / Pharmacology / Clinical research / Pharmaceutical sciences

FY 2013 BsUFA Financial Report - Executive Summary

Add to Reading List

Source URL: www.fda.gov

Language: English
297Pharmacology / Food and Drug Administration / Biosimilar / Biotechnology / Drugs / Pharmaceutical industry / Biologic / Generic drug / Center for Drug Evaluation and Research / Medicine / Health / Pharmaceutical sciences

FOOD and DRUG FDLI’S POLICY FORUM

Add to Reading List

Source URL: healthybiologics.org

Language: English - Date: 2014-08-27 14:35:53
298Medicine / Clinical pharmacology / Drugs / Medical prescription / Patient safety / Biosimilar / Biologic / Pharmacist / Pharmacy / Pharmacology / Pharmaceutical sciences / Clinical research

*PD3287* PRELIMINARY DRAFT No[removed]PREPARED BY LEGISLATIVE SERVICES AGENCY

Add to Reading List

Source URL: www.in.gov

Language: English - Date: 2014-03-03 17:00:46
299Medicine / Pharmaceutical sciences / Biologic / Biosimilar / Center for Biologics Evaluation and Research / Full-time equivalent / Center for Drug Evaluation and Research / Pharmacology / Clinical research / Food and Drug Administration

FY 2013 BsUFA Financial Report

Add to Reading List

Source URL: www.fda.gov

Language: English
300Cell lines / Cell culture / Life Technologies / Invitrogen / Stem cell / Biosimilar / Biologic / Biology / Biotechnology / Cell biology

InVitria Taps Industry Expert to Launch Cell Culture Supplements Product Line Fort Collins, CO January 20, 2011 – InVitria announced the expansion of its sales and marketing team with the addition of Shawn Smith as Vic

Add to Reading List

Source URL: wichitatechnology.com

Language: English - Date: 2011-01-21 15:52:58
UPDATE